Ignite Creation Date:
2025-12-24 @ 4:53 PM
Ignite Modification Date:
2026-05-02 @ 12:27 AM
Study NCT ID:
NCT03201250
Status:
TERMINATED
Last Update Posted:
2023-09-08
First Post:
2017-06-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Sponsor:
Organization: